Estrogen dysregulation, intraocular pressure, and glaucoma risk
Authors:
- 11 November 2023
- journal article
- review article
- Published by Elsevier in Experimental Eye Research
- Vol. 237, 109725
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- BrightFocus Foundation
- National Eye Institute (F31EY031973, P30EY005722, P30EY031631, R01EY022359, R01EY023242, R01EY023287, R01EY028608, R21EY028671)
- National Youth Council Singapore
- Glaucoma Research Foundation
- Research to Prevent Blindness
- Fight for Sight
- Glaucoma Foundation
This publication has 255 references indexed in Scilit:
- Integrins in Trabecular Meshwork and Optic Nerve Head: Possible Association with the Pathogenesis of GlaucomaBioMed Research International, 2013
- Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Endothelial Nitric Oxide Synthase Gene Variants and Primary Open-Angle GlaucomaArchives of Ophthalmology (1950), 2011
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- The changing paradigm of outflow resistance generation: Towards synergistic models of the JCT and inner wall endotheliumExperimental Eye Research, 2009
- Glaucoma-associated myocilin: A better understanding but much more to learnExperimental Eye Research, 2009
- Biological properties of trabecular meshwork cellsExperimental Eye Research, 2009
- Vascular cell signaling by membrane estrogen receptorsSteroids, 2008
- Extracellular matrix in the trabecular meshworkExperimental Eye Research, 2008
- Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor βExperimental Eye Research, 2007